Week 4 lecture 2 b-lymphocyte development.
B-lymphocyte Development
Development of B-lymphocytes occurs primarily in primary lymphoid organs (bone marrow) and secondary lymphoid organs (spleen and lymph nodes).
Primary Lymphoid Tissues (Yellow): These are sites where lymphocytes mature and become immunocompetent.
Bone Marrow: Serves as the primary site for the development of all lineages of blood cells, including B lymphocytes. In the bone marrow, B cell precursors undergo antigen-independent differentiation, acquiring their unique B cell receptors (BCR). Note: In birds, an analogous organ called the Bursa of Fabricius is involved in B cell development.
Thymus: The primary site for T cell development and maturation.
Secondary Lymphoid Tissues (Blue): These organs are crucial for initiating adaptive immune responses by facilitating interactions between lymphocytes and antigens.
Organs include the spleen, lymph nodes, and various mucosal-associated lymphoid tissues (MALT). They are the sites where mature, naïve B cells encounter antigens, become activated, and differentiate into effector cells.
The circulatory systems, including blood and lymph, connect lymphoid organs and transport immune cells throughout the body.
To be functional, B cells must:
Accurately recognize foreign antigens via their B cell receptor (BCR), initiating an immune response.
Effectively ignore self-antigens through processes of central and peripheral tolerance to prevent autoimmunity.
B Cell Lineage Development
The journey of a B cell begins from a Hematopoietic Stem Cell (HSC) in the bone marrow.
HSCs differentiate into a Common Myeloid Progenitor (CMP) or a Common Lymphoid Progenitor (CLP).
The Common Lymphoid Progenitor (CLP) is a multipotent cell type that develops into various lymphoid cell types, including T cells, B cells, and Natural Killer (NK) cells.
B Cell Receptor (BCR): This is a membrane-bound immunoglobulin (Ig) molecule (typically IgM or IgD) expressed on the surface of B cells. It is responsible for specific antigen binding, which, upon cross-linking, initiates intracellular signaling pathways leading to B cell proliferation, differentiation, and effector functions. The BCR complex includes Ig and Ig signaling molecules.
Immunoglobulins (Ig): Also known as antibodies, these are glycoprotein molecules that function as antigen receptors on B cells (membrane BCR) and as soluble effector molecules in bodily fluids (secreted antibodies). They are critical components of humoral immunity.
Immunoglobulin Structure
Immunoglobulin molecules are fundamentally composed of two identical heavy ($\mu$, $\delta$, $\gamma$, $\alpha$, or $\epsilon$) and two identical light chains (kappa ($\kappa$) or lambda ($\lambda$)), which are linked together by interchain disulfide bonds to form a Y-shaped molecule.
Variable (V) and Constant (C) Regions:
Variable (V) regions: Located at the amino-terminal ends of both heavy and light chains, these regions display high sequence variability and form the antigen-binding sites, responsible for the specificity of antigen recognition. Each Ig molecule has two identical antigen-binding sites (Fab regions).
Constant (C) regions: Located at the carboxyl-terminal ends, these regions exhibit less variability within each isotype. The heavy chain constant region determines the antibody's isotype (e.g., IgM, IgG, IgA), its effector functions, and its tissue distribution (Fc region).
Light chains can be one of two types: kappa ($\kappa$) or lambda ($\lambda$), encoded by genes on different chromosomes, but any single immunoglobulin molecule contains either two $\kappa$ or two $\lambda$ chains, never one of each.
Typical Structure of Immunoglobulin:
Composed of 2 heavy chains and 2 light chains. The two heavy chains are connected by disulfide bonds in a flexible hinge region, which allows for flexibility in antigen binding. The light chains are each connected to a heavy chain by a disulfide bond, forming the characteristic Y-shape.
Development Phases of B Cells in Bone Marrow
1. Primary Lymphoid Organ (Bone Marrow)
B cell development in the bone marrow is an antigen-independent process where progenitor cells differentiate through a series of stages, acquiring a unique BCR:
Common Lymphoid Progenitor (CLP): The earliest progenitor cell committed to the lymphoid lineage.
Pro-B Cell: Undergoes D-J recombination of the heavy chain gene segment, followed by V-DJ recombination.
Pre-B Cell: Expresses a pre-B cell receptor (pre-BCR), indicating successful heavy chain rearrangement. Subsequently, light chain gene rearrangement begins.
Immature B Cell: Successfully expresses a functional membrane-bound IgM B cell receptor. This stage marks the completion of antigen receptor assembly.
This development process is antigen-independent until the immature stage, meaning gene rearrangements occur randomly to generate a vast repertoire of BCRs before encountering specific antigens.
2. Central Tolerance Development:
Immature B cells, having assembled their BCR, undergo stringent selection processes to ensure self-tolerance and functionality. This selection is crucial for preventing autoimmune reactions.
Checkpoints for development:
Checkpoint #1 (Pro-B to Pre-B transition): The Pre-BCR is expressed on the cell surface, consisting of a successfully rearranged heavy chain paired with surrogate light chains. Successful signaling through the pre-BCR indicates a functional heavy chain rearrangement, allowing the cell to proliferate and proceed to light chain rearrangement. Failure to signal leads to apoptosis.
Checkpoint #2 (Immature B cell in bone marrow - Central Tolerance): Immature B cells expressing surface IgM are tested for self-reactivity against bone marrow-resident self-antigens. This negative selection removes or inactivates self-reactive BCR clones. Highly self-reactive B cells undergo receptor editing (further light chain rearrangement) or apoptosis (clonal deletion), while weakly self-reactive B cells may become anergic (functionally inactive).
Checkpoint #3 (Transitional B cells in peripheral tissues - Peripheral Tolerance): B cells that survive central tolerance exit the bone marrow and mature further in peripheral lymphoid organs (e.g., spleen). Here, additional negative selection checkpoints occur, where self-reactive B cells that escaped central tolerance can be anergized, deleted, or suppressed to maintain peripheral tolerance.
BCR Recombination and Selection
The generation of diverse B cell receptors occurs through somatic gene recombination, specific assembly of variable, diversity, and joining (VDJ) gene segments.
Heavy chain recombination occurs first involving D-J gene segment joining, followed by V-DJ rearrangement. This process is mediated by Recombination-Activating Genes (RAG-1 and RAG-2) enzymes.
Light chain recombination (V-J joining) follows, but only after successful heavy chain rearrangement and pre-BCR expression.
Checkpoints for Recombination
Checkpoint #1: Pre-BCR Testing
This stage is crucial for validating a functional heavy chain. The expression of a pre-BCR (heavy chain + surrogate light chain + Ig/Ig) on the cell surface sends a signal that arrests heavy chain recombination, induces proliferation, and initiates light chain recombination. This ensures that B cells proceed with a functional heavy chain.
Negative Selection: Testing for self-reactivity occurs in two critical phases:
In the Bone Marrow: Immature B cells are screened for reactivity against self-antigens. If strong self-reactivity is detected, the cell may undergo receptor editing (rearrangement of another light chain gene) to alter its specificity. If editing fails or if reactivity is too strong, the B cell undergoes apoptosis.
In the Spleen (or other peripheral lymphoid organs): Immature B cells that have passed bone marrow selection mature into transitional B cells. Here, surface IgM must not react strongly to self-antigens to avoid anergy or further apoptosis. Those that successfully avoid self-reactivity fully mature into follicular B cells or marginal zone B cells.
B Cell Migration and Activation
Mature naïve B cells, expressing both surface IgM and IgD, exit the bone marrow and migrate to secondary lymphoid organs, where they circulate awaiting antigen encounter.
Categories of B cells include:
Follicular B cells: The majority of B cells. They circulate between lymphoid organs and reside mainly in the follicles of the spleen and lymph nodes. They are primarily responsible for T-dependent antibody responses to protein antigens.
Marginal zone B cells: Reside specifically in the marginal zone of the spleen, an area rich in blood-borne antigens. They are involved in rapid T-independent responses, typically to carbohydrate and lipid antigens from pathogens.
B-lymphocyte Activation
B Cell Activation, the process by which a resting B cell becomes an active effector cell, primarily occurs in specialized microenvironments within secondary lymphoid organs:
Spleen: Filters blood-borne antigens and is crucial for systemic immune responses.
Lymph nodes: Filter lymph fluid and are key sites for immune responses to tissue-derived antigens.
Gut-associated lymphoid tissue (GALT): Includes Peyer's patches, tonsils, and appendix, involved in mucosal immunity.
Activation Process
Recognition Phase:
Resting B cells are characterized by the co-expression of surface IgM (sIgM) and surface IgD (sIgD). Both act as antigen receptors, though IgD's precise signaling role is less understood. Antigen binding to the BCR provides the initial activation signal.
Activation Phase:
Following antigen recognition and often requiring interaction with helper T cells (for T-dependent antigens), B cells undergo clonal expansion (rapid proliferation). This leads to the differentiation of B cells into various effector and memory cells.
Resulting in:
Activated B cells: Proliferating cells that are actively responding to antigen.
Plasma cells: Terminally differentiated B cells that are highly specialized for secreting large quantities of antibodies. These can be short-lived or long-lived.
Memory B cells: Long-lived, quiescent cells that provide enhanced and rapid responses upon subsequent exposure to the same antigen.
Isotype switching (Class Switch Recombination, CSR): Activated B cells can change the constant region of their heavy chain, switching from producing IgM to other isotypes like IgG, IgA, or IgE, while maintaining antigen specificity. For instance, IgG-expressing B cells develop from mature naïve B cells following specific T cell signals.
Types of B Cell Activation
T-dependent activation: This type of activation requires direct help from activated Follicular Helper T (TFH) cells. It typically occurs in response to protein antigens. This interaction leads to a robust immune response characterized by:
High-affinity antibody production through affinity maturation.
The generation of long-lived plasma cells and memory B cells.
Extensive isotype switching to various Ig classes (IgG, IgA, IgE).
The interaction involves the B cell presenting processed antigen peptides via MHC class II to the TFH cell's TCR, along with co-stimulatory signals like CD40-CD40L engagement.
T-independent activation: This pathway does not require T cell help. It is typically elicited by non-protein antigens, such as bacterial polysaccharides or lipopolysaccharides (LPS), which can directly activate B cells by extensively cross-linking multiple BCRs or by engaging pattern recognition receptors (e.g., TLRs).
Primarily yields low-affinity IgM antibodies.
Generates a limited memory response and little to no isotype switching.
There are two main types: TI-1 antigens (e.g., LPS, which can act as mitogens) and TI-2 antigens (e.g., repetitive polysaccharide antigens), differing in their requirement for co-stimulation.
Thymus-Dependent Antigen Interaction
B cells' recognition of protein antigens is most effective in the presence of T-cell help within secondary lymphoid organs.
Linked Recognition: The B cell internalizes the specific protein antigen via its BCR, processes it, and presents peptide fragments on MHC class II molecules on its surface. A helper T cell (specifically a TFH cell) recognizes this same peptide on the B cell's MHC class II, provided the T cell's TCR is specific for that peptide. This interaction activates signaling pathways in the B cell (including AP-1, NFAT, and NF-kB) leading to proliferation and differentiation.
Outputs from T cell help:
B cells undergo proliferation and migrate towards the outer and interfollicular regions of the lymphoid organ, forming germinal centers.
Some activated B cells can immediately differentiate into short-lived plasmablasts (antibody-secreting cells) in the extrafollicular regions.
Other B cells, often with higher affinity BCRs, remain in the follicles and enter the germinal center reaction to further refine their antibody response.
Germinal Center Reaction
The germinal center (GC) is a specialized microenvironment within secondary lymphoid follicles where B cells undergo extensive proliferation and intricate processes to optimize antibodies. These processes include:
Somatic hypermutation (SHM): Introducing point mutations in the variable regions of immunoglobulin genes.
Affinity maturation (AM): The selection and expansion of B cell clones with higher affinity receptors for the antigen.
Class switch recombination (CSR): Changing the isotype of the antibody produced.
GC Structure
Germinal centers are dynamically structured into distinct zones:
Dark Zone: Characterized by dense populations of rapidly proliferating B cells called centroblasts. This is the primary site where somatic hypermutation occurs, introducing random point mutations into the V regions of the heavy and light chain genes.
Light Zone: Centrocytes (B cells derived from centroblasts that have undergone SHM) interact with follicular dendritic cells (FDCs) that present intact antigens, and with TFH cells. Here, selection based on affinity takes place: B cells with higher affinity BCRs for the antigen are preferentially selected and receive survival signals from TFH cells. Unsuccessful B cells undergo apoptosis. Selected B cells can then undergo further rounds of mutation, affinity maturation, and class switch recombination to form high-affinity antibodies.
Diversification and Mutation Processes
Several key molecular processes contribute to antibody diversity and improved function during the immune response:
Somatic hypermutation (SHM): Introduces random point mutations at a very high rate into the variable region genes of activated B cells, primarily in germinal centers. This process generates new receptor specificities, some with increased affinity for the antigen.
Gene conversion: While more prominent in birds (e.g., in the bursa of Fabricius), this mechanism in mammals can contribute to antibody diversity by replacing gene segments with pseudogenes, though its role in human B cell diversification is minimal compared to SHM.
Class switch recombination (CSR): A DNA recombination event that replaces the original heavy chain constant region gene (IgM or IgD) with another constant region gene (IgG, IgA, or IgE), thereby changing the antibody's effector function while retaining its antigen specificity.
All these processes (SHM, CSR) depend critically on the enzyme Activation-Induced Cytidine Deaminase (AID), which deaminates cytosine residues in DNA, initiating the molecular events for mutation and recombination. These mutations and recombinations allow for a significant improvement in antibody affinity to specific antigens and adaptation of antibodies for various effector functions.
Antibody Classes and Isotypes
Each antibody isotype performs distinct effector functions:
IgM: Typically pentameric when secreted (five antibody molecules joined), making it a large molecule. It is the first antibody produced during a primary immune response and has very high avidity (overall binding strength due to multiple binding sites). It is highly efficient at activating the complement system but does not cross the placenta. It is primarily found in the bloodstream.
IgG: The most abundant immunoglobulin in serum (about ), typically monomeric. It is associated with a secondary immune response, characterized by high-affinity binding. IgG is the only antibody class that crosses the placenta, providing passive immunity to the fetus. It mediates neutralization of toxins and pathogens, opsonization, antibody-dependent cell-mediated cytotoxicity (ADCC), and complement activation. There are four subclasses (IgG1, IgG2, IgG3, IgG4) with slight functional differences.
IgA: Predominantly dimeric with a secretory component, found at mucosal surfaces (e.g., gut, respiratory tract, urogenital tract) and in bodily secretions like tears, saliva, and breast milk. It plays a critical role in mucosal immunity by neutralizing pathogens and toxins before they can enter the body. It is passed via breast milk to provide passive immunity to infants.
IgE: Monomeric, found in very low concentrations in serum. It is primarily involved in mediating allergic reactions and defense against parasites (e.g., helminths). IgE binds with high affinity to Fc receptors on mast cells and basophils, leading to the release of inflammatory mediators upon antigen binding.
Functional Classes of Antibodies
Effector Functions of Antibodies describe the ways antibodies protect the host from pathogens:
Neutralization of toxins and pathogens: Antibodies (e.g., IgG and IgA) directly bind to toxins, viruses, or bacteria, preventing them from interacting with host cells and causing damage or infection. This is particularly effective for blocking pathogen entry.
Opsonization: Antibodies (especially IgG and IgM) coat the surface of pathogens, making them more easily recognized and ingested by phagocytic cells (macrophages and neutrophils) that have Fc receptors. This enhances phagocytosis and clearance.
Complement activation: IgM (highly efficient) and IgG can bind to pathogen surfaces and initiate the classical complement pathway, leading to the formation of the membrane attack complex (MAC) that lyses pathogens, enhances opsonization, and generates inflammatory mediators.
Antibody-Dependent Cell-mediated Cytotoxicity (ADCC): Certain IgG antibodies can bind to target cells (e.g., virus-infected cells or tumor cells) and then be recognized by Fc receptors on NK cells, leading to the killing of the target cell.
Summary of Immunoglobulin Functions
Antibody isotypes significantly influence:
Their distinct tissue distribution throughout the body and secretions.
The specific immune functions and responses they mediate against various types of pathogens and threats.
Antibody efficacy depends critically on:
Avidity: The overall strength of binding between a multivalent antibody and a multivalent antigen. This is especially important for antibodies like pentameric IgM, which has multiple binding sites.
Affinity: The strength of binding between a single antigen-binding site on an antibody and a single epitope on an antigen. Affinity maturation increases this intrinsic binding strength.
Recommended Reading
Janeway's Immunobiology, Tenth Edition
Chapters to focus: 4, 5, 8, & 10 of Immunobiology and Basic Immunology authors by Abbas et al.